Charles River Laboratories International, Inc. (CRL) Revenue History
Charles River Laboratories International, Inc. (CRL) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $1.68B |
| 2017-12-31 | $1.86B |
| 2018-12-31 | $2.27B |
| 2019-12-31 | $2.62B |
| 2020-12-31 | $2.92B |
| 2021-12-31 | $3.54B |
| 2022-12-31 | $3.98B |
| 2023-12-31 | $4.13B |
| 2024-12-31 | $4.05B |
| 2025-12-31 | $4.02B |
How CRL compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| ILMN | Illumina Inc. | $4.34B |
| PRGO | Perrigo Company plc | $4.25B |
| ALGN | Align Technology Inc. | $4.03B |
| ALNY | Alnylam Pharmaceuticals Inc. | $3.71B |
| BRKR | Bruker Corporation | $3.44B |
These are five companies in the same sector as CRL with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Charles River Laboratories International, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("CRL", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CRL | $280.05 | -0.43% | 0.75M |
| 3 | ||||
| 4 | ||||
| 5 |